Irena Seredina’ background is medicine, economics and management. She holds an MD, honors diploma and a MSc in Health Economics. During her medical practice, Irena worked in clinical research as a researcher and an investigator. The results of her research have been published in a number of articles and she is a recognized speaker at several industry forums and international conferences. Irena worked at Amgen, and then joined S-Clinica in 2004. Now, as Executive Director Irena gives direction for the product strategy and customer relationships.
Archives: Speakers
Jasvinder Osan
Jas started his career in the 90s, as a data manager within clinical trials when these were done predominantly on paper – and has over the years seen the industry change and evolve.
He has a degree in Applied Physics, and has worked over the last 25 years within eClinical technologies and solutions, with global responsibilities in project management, solutions consulting and sales. Jas’s role within S-CLINICA is to bring new business, and build strategic relationships with customers.
Josh McCusker
Josh is Head of Insurance at Urban Jungle, an Insurtech that is crafting insurance for a new generation, where cover is simple, clear and fair.
Josh works with Urban Jungle’s underwriting partners to bring innovative insurance products to market, with a relentless focus on utilising technology to deliver a truly digital insurance experience.
Josh started his career in Insurance at Allianz, working across commercial fleet underwriting, technical claims, pet insurance partnerships & sales. He then worked as Executive Assistant to the Chief Operating Officer, supporting the development and delivery of the UK Operations strategy through a period of significant change, including the acquisition of LV= and L&G GI.
Josh is passionate about delivering truly valuable insurance products to customers that are easy to both understand and use at point of sale and claim.
Jos Deschagt
Jos is Operations Director of Engilico and has over 15 years experience in packaging and food industry. Mr Deschagt is also sales responsible for UK, FR and US region.
Renaat Van Cauter
Renaat Van Cauter has gained a broad experience in technology marketing through various positions in engineering and innovation-driven companies. At Engilico, he focuses on raising awareness within the packaging industry about the capabilities of in-line seal inspection and lead generation.
Olivier Georis
Olivier Georis, co-founder of Engilico, boasts extensive managing experience in technology-driven companies in wide variety of industry sectors, today more specifically in packaging and inspection business. In 2021, Engilico became part of Japanese packaging company PACRAFT, a division of large engineering group Nabtesco. With a career marked by a commitment to excellence and growth in various engineering companies, Olivier Georis plays a pivotal role in leading Engilico towards the next steps within PACRAFT and Nabtesco.
Dr Greg B Davies
How can behavioural science help clients to achieve better financial outcomes? How can you make better investment decisions? What really matters to investors? How do advisers keep clients invested for the long-term?
Greg Davies, Head of Behavioural Finance at Oxford Risk, combines academic rigour and real-life industry experience to answer these questions and provide valuable insights across a wide range of behavioural finance topics.
He founded and led the banking world’s first behavioural finance team at Barclays where he was a Managing Director and Head of Behavioural Quant Finance for a decade. His PhD in Behavioural Decision Theory was awarded by the University of Cambridge, and he is a specialist in both the theory and practice of investment decision making and financial advice.
At Oxford Risk he leads the development of its behavioural decision support software aimed at helping wealth managers and their clients to make the best possible financial decisions.
He has been a visiting lecturer at Imperial College London, held associate fellowships at Oxford’s Said Business School and University College London, and is the co-author of the book Behavioral Investment Management
Subs Tripathy
Hal J. Mann
I am a Clinical Research Professional with more than 30 years of experience ranging in perspective from the Study Site, small and large CRO’s, large Pharma, and large Diagnostics companies. During my 15 years with GlaxoSmithKline, I spent my early years designing and conducting Clinical Trials before focusing on supplier management and strategic outsourcing. In 2013, I joined Roche Molecular in Pleasanton, CA, where I currently lead a chapter in Clinical Development and Medical Affairs delivering Clinical Contracts & Outsourcing, Clinical Supplies Management, Functional Excellence / Clinical Quality, Clinical IT Solutions and Analytics, and sample management and testing from our internal Clinical Trial Support Lab.